Article

Botulinum Toxin Type A: Efficacy and Safety Profile in the Treatment of Lower Limb Spasticity in Children with genetic Disorders

2023-08-30

Abstract excerpt

<h4>Background: </h4> Botulinum toxin type A (BTX-A) is a well-established therapeutic modality for the treatment of lower limb spasticity in children with cerebral palsy. There is paucity of evidence about its effectiveness and safety in genetic disorders. <h4>Objective: </h4> To assess the functional outcomes and safety of BTX-A injection for the treatment of lower limb spasticity in children with genetic disor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f06a080a-d72e-540f-9904-8ea7694127cc
DOI: 10.21203/rs.3.rs-3212737/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Botulinum Toxin Type A: Efficacy and Safety Profile in the Treatment of Lower Limb Spasticity in Children with genetic DisordersDOI 10.21203/rs.3.rs-3212737/v1Read

Botulinum Toxin Type A: Efficacy in the management of Lower Limb Spasticity in Children with Genetic DisordersSemantic proximity Read

Characteristics of individuals with cerebral palsy across the United StatesSemantic proximity Read

Movement disorder phenotype in CTNNB1-syndrome: A complex but recognizable phenomenology.Semantic proximity Read

Clinical actionability of genetic findings in cerebral palsySemantic proximity Read

Clinical and electrophysiologic features of the Pediatric hereditary neuropathy with liability to pressure palsiesSemantic proximity Read

Safety and Efficacy of Vesemnogene Lantuparvovec, an AAV-Based Gene Therapy in Young Children Under 24 Months with Spinal Muscular Atrophy in Low- and Middle-Income Countries. Second Interim Report (August 2025)Semantic proximity Read

Botulinum toxin as adjuvant therapy for hypertonic dysfunction in a neuro-rehabilitation cohortSemantic proximity Read

HPDL Biallelic Variants in Cerebral Palsy and Childhood‐Onset Hereditary Spastic Paraplegia: Human and Zebrafish InsightsSemantic proximity Read

Clinical Actionability of Genetic Findings in Cerebral PalsySemantic proximity Read

Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral PalsySemantic proximity Read

Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural history.Semantic proximity Read

2024 update: European consensus statement on gene therapy for spinal muscular atrophySemantic proximity Read